GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Unknown  (2)
  • 1
    Online Resource
    Online Resource
    Harborside Press, LLC ; 2019
    In:  Journal of the National Comprehensive Cancer Network Vol. 17, No. 11 ( 2019-11), p. 1396-1401
    In: Journal of the National Comprehensive Cancer Network, Harborside Press, LLC, Vol. 17, No. 11 ( 2019-11), p. 1396-1401
    Abstract: Gestational trophoblastic disease refers to a series of interrelated tumors arising from the placenta, including benign molar pregnancies as well as the malignant conditions termed gestational trophoblastic neoplasia (GTN). GTN most commonly follows a molar pregnancy but may develop after any gestation. The wide availability of first trimester ultrasound and serum human chorionic gonadotropin (hCG) measurement has changed the presentation of molar pregnancy in recent decades from a second trimester to a first trimester disease, such that most patients have few symptoms at diagnosis. With identification of molar pregnancy at earlier gestations, accurate diagnosis increasingly relies on expert histopathology coupled with ancillary molecular and genetic techniques. However, earlier diagnosis has not changed the risk of postmolar GTN. Although most molar pregnancies are treated with dilation and curettage, hysterectomy may be appropriate in select cases when future fertility is not desired. After treatment of molar pregnancy, close surveillance with serial hCG monitoring is essential to diagnose GTN and identify the need for chemotherapy. Physicians following hCG levels should understand the performance characteristics of the test, including common causes of false-positive and false-negative results. After a diagnosis of postmolar GTN is made, selection of single-agent or multiagent chemotherapy depends on accurate assignment of the clinical stage and risk stratification by the International Federation of Gynecology and Obstetrics (FIGO) prognostic scoring system. Surgical treatment of postmolar low-risk GTN, including both second uterine curettage and hysterectomy, may decrease subsequent need for or duration of chemotherapy. Cure rates for postmolar low-risk GTN approach 100%, and subsequent pregnancy outcomes for patients reflect those of the general population.
    Type of Medium: Online Resource
    ISSN: 1540-1405 , 1540-1413
    Language: Unknown
    Publisher: Harborside Press, LLC
    Publication Date: 2019
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    Akademiai Kiado Zrt. ; 2022
    In:  Orvosi Hetilap Vol. 163, No. 19 ( 2022-05-08), p. 734-742
    In: Orvosi Hetilap, Akademiai Kiado Zrt., Vol. 163, No. 19 ( 2022-05-08), p. 734-742
    Abstract: Összefoglaló. A sikeres fogantatás, beágyazódás és terhesség komplex és szervezett kommunikációt igényel az embrió (allograft) és az anya (gazda) immunrendszere között. A különböző leukocyta-alcsoportok fontos szerepet játszanak az immunválasz szervezésében a magzati–anyai határfelületen. Vannak bizonyos hasonlóságok a tumorsejteknek az immunrendszert kijátszó kóros és az embrionális eredetű trophoblastsejteknek az anyai deciduába irányuló fiziológiás inváziója között. A decidualis vagy uterinalis természetes ölősejtek a természetes ölősejtek speciális részhalmaza, és a macrophagokkal és a dendritikus sejtekkel együtt a veleszületett immunrendszer részét képezik, ezért ők az első immunsejtek, amelyek kapcsolatba lépnek bármely behatolóval, legyen az daganat vagy embrionális szövet. Érdekes módon a decidualis természetes ölősejtek nemcsak nem támadják meg az invazív trophoblastsejteket, hanem kifejezetten elősegítik azok progresszióját. Angiogenikus aktivitásuk megkönnyíti és koordinálja a kialakuló méhlepény helyi vascularis átalakulását. Dolgozatunkban áttekintjük a trophoblastsejtek és a decidualis természetes ölősejtek kölcsönhatásait, a decidualis természetes ölősejtek szerepét a decidua vascularisatiójában és immunháztartásában. Orv Hetil. 2022; 163(19): 734–742. Summary. Successful conception, implantation and pregnancy require a complex and organized communication between the embryonal (allograft) and the maternal (host) immune system. Different leukocyte subsets have an important role in orchestrating the immune response at the fetal-maternal interface. There are certain similarities between the immune invasion of tumor cells and the physiological invasion of the trophoblastic cells of embryonic origin into the maternal decidua. The decidual natural killer cells are a special subset of natural killer cells and alongside with macrophages and dendritic cells, they are part of the innate immune system therefore they are the first immune cells contacting any intruder whether it is a tumor or embryonic tissue. Interestingly decidual natural killer cells not only do not eliminate invasive trophoblastic cells, but specifically promote their progression. Their angiogenic activity facilitates and coordinates local vascular remodeling of the forming placenta. In this article we review the different nature of trophoblastic cell and decidual natural killer cell interaction, the role of decidual natural killer cells in the vascularization and immune homeostasis of the decidua. Orv Hetil. 2022; 163(19): 734–742.
    Type of Medium: Online Resource
    ISSN: 0030-6002 , 1788-6120
    Language: Unknown
    Publisher: Akademiai Kiado Zrt.
    Publication Date: 2022
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...